SAVIMS

SAVIMS logo white
Menu

Resource Type

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Long Haul COVID-19 Syndrome: Management and Treatment Protocols

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19: Management protocol for Long Haul COVID-19 Syndrome (LHCS). Retrieved from https://flccc.net/flccc-protocols-a-guide-to-the-management-of-covid-19 Summary: The Front Line COVID-19 Critical Care Alliance (FLCCC) has developed a consensus protocol for managing Long Haul COVID-19 Syndrome (LHCS), which presents a range of symptoms including fatigue, cognitive […]

Other scientific evidence, Resource Type, Treatment

Human Cells Can Rewrite RNA into DNA: A Groundbreaking Discovery

| | Other scientific evidence, Resource Type, Treatment

Reference: Rees, V. (2021, June 14). Human cells can write RNA sequences into DNA, study shows. Drug Target Review. https://www.drugtargetreview.com/news/92931/human-cells-can-write-rna-sequences-into-dna-study-shows/ Summary: Researchers at Thomas Jefferson University have discovered that human polymerase theta can convert RNA segments back into DNA, challenging the traditional understanding of molecular biology. This finding suggests that RNA messages may serve as

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Efficacy and Safety of Single-Dose Ad26.COV2.S Covid-19 Vaccine

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., Neuzil, K. M., Corey, L., Cauwenberghs, N., Tanner, T., Hardt,

COVID-19, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Viral illnesses

Improved Diagnosis of SARS-CoV-2 Using Nucleoprotein and Spike Protein Fragment in ELISA Tests

| | COVID-19, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Viral illnesses

Reference: De Marco Verissimo, C., O’Brien, C., López Corrales, J., Dorey, A., Cwiklinski, K., Lalor, R., … & Doyle, S. (2021). Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiology and Infection, 149, e140, 1–11. https://doi.org/10.1017/S0950268821001308 Summary: The article discusses advancements in diagnosing SARS-CoV-2 through the

Ethics, Other scientific evidence, Reference Library, Resource Type

The Heartbreaking Reality of South Africa’s Healthcare System

| | Ethics, Other scientific evidence, Reference Library, Resource Type

Reference: De Maayer, T. (2022). How do you manage to come to work every day, fail at your job of ensuring basic healthcare for the people you serve and still sleep at night? DM168. Summary: In a poignant open letter, Dr Tim De Maayer, a paediatrician at Rahima Moosa Mother and Child Hospital, sheds light

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Dr Chetty’s 8th Day Therapy for COVID-19: A Summary

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Chetty, S. (2021). Dr Chetty’s 8th day therapy for COVID-19. Covexit. Retrieved from [URL] Summary: Dr Shankara Chetty’s 8th Day Therapy for COVID-19 addresses the inflammatory phase occurring after Day 8 of infection, aiming to prevent severe disease progression. The document outlines four key interventions starting at this critical juncture. First, corticosteroids like Prednisone

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

I-MASS Protocol for COVID-19 Treatment

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/ Summary: The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Efficacy of NVX-CoV2373 Vaccine against B.1.351 Variant

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., … & Madhi, S. A. (2021). Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. The New England Journal of Medicine, 384(20), 1899-1909. https://doi.org/10.1056/NEJMoa2103055 Summary: The NVX-CoV2373 nanoparticle vaccine was evaluated in a phase 2 trial in South Africa during the B.1.351

COVID-19, Covid-19 vaccines, Ethics, Genetic vaccines, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Merriam-Webster Updates Definition of “Vaccine”

| | COVID-19, Covid-19 vaccines, Ethics, Genetic vaccines, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Reference: Mair, V. (2021, April 30). Merriam-Webster gives “vaccine” a new definition. Language Log. Retrieved from https://languagelog.ldc.upenn.edu/nll/?p=50886 Summary: In a recent post, Victor Mair discusses an update to the definition of “vaccine” by Merriam-Webster. While traditional definitions describe vaccines as preparations of weakened or killed pathogens, the new entry expands this definition significantly. It now

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Ethics, Other scientific evidence, Reference Library, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Monitoring the Effectiveness of the Ad26.COV2.S COVID-19 Vaccine in South African Healthcare Workers

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Ethics, Other scientific evidence, Reference Library, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: South African Medical Research Council. (2021). Sisonke Protocol Version 4.4 dated 29 Apr 2021. Summary: The Sisonke Protocol is an open-label, single-arm phase 3B study aimed at evaluating the effectiveness of the Ad26.COV2.S COVID-19 vaccine among healthcare workers in South Africa. This study involves approximately 500,000 healthcare workers aged 18 and older, who will

Scroll to Top